NKTR
HEALTHYNEKTAR THERAPEUTICS
CIK: 0000906709
Sell
(50% confidence)
Last activity: 3 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Revenue $148.92M
Net Income -$8.20M
Total Cash $414.90M
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Zalevsky Jonathan Chief R&D Officer | 0 | 2 | -$201K | 21,354 shares $762K |
| ROBIN HOWARD W President & CEO | 0 | 1 | -$120K | 54,245 shares $2.94M |
| Wilson Mark Andrew Chief Legal Officer | 0 | 1 | -$34K | 21,585 shares $1.17M |
Recent Transactions
SELL Zalevsky Jonathan (Chief R&D Officer)
3,867 shares @ $35.67
$138K
Jan 20, 2026
Conviction: |
View SEC Filing →
SELL ROBIN HOWARD W (President & CEO)
2,207 shares @ $54.28
$120K
Nov 25, 2025
Conviction: |
View SEC Filing →
SELL Zalevsky Jonathan (Chief R&D Officer)
1,157 shares @ $54.28
$63K
Nov 25, 2025
Conviction: |
View SEC Filing →
SELL Wilson Mark Andrew (Chief Legal Officer)
630 shares @ $54.28
$34K
Nov 25, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.